Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bachem
Bubendorf, Basel-Landschaft, Switzerlandbachem.com ↗
- Ownership
- Public · BANB
- Employees
- ~2200
- Development stage
- Commercial
01
Overview
Bachem is a global leader in the development and manufacture of peptides and oligonucleotides as active pharmaceutical ingredients. It serves pharmaceutical and biotech companies worldwide with products spanning research to commercial scale. The company does not have its own clinical pipeline but enables client programs across all stages.
- Modalities
- PeptidesOligonucleotidesSmall molecule APIs
- Industry
- Contract Manufacturing Organization
02
Partnerships
GlyTech Inc.
03
Financials
- Market cap
- $7.2B
- Total revenue
- $849.6M
- Enterprise value
- $7.4B
Beyond the preview
Go deeper on Bachem.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bachem.